W H F Goessens

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum β-lactamases in experimental pneumonia in rats
    Wil H F Goessens
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Antimicrob Agents Chemother 57:643-6. 2013
  2. ncbi A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA)
    Andreas Voss
    Radboud University Nijmegen Medical Centre, Nijmegen University Centre of Infectious Diseases, The Netherlands
    Ann Clin Microbiol Antimicrob 6:9. 2007
  3. ncbi [Antibiotic resistance: epidemiological developments and preventive measures]
    W H F Goessens
    Medische Microbiologie en Infectieziekten, s Gravendijkwal 230, 3015 CE Rotterdam
    Ned Tijdschr Geneeskd 151:748-52. 2007
  4. ncbi Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection
    W H F Goessens
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Antimicrob Chemother 59:507-16. 2007
  5. ncbi Comparison of the COBAS AMPLICOR MTB and BDProbeTec ET assays for detection of Mycobacterium tuberculosis in respiratory specimens
    W H F Goessens
    Erasmus MC, University Medical Center Rotterdam, Dept of Medical Microbiology and Infectious Diseases, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    J Clin Microbiol 43:2563-6. 2005
  6. ncbi Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type
    A K van der Bij
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Clin Microbiol Infect 18:E369-72. 2012
  7. ncbi Dynamics of pneumococcal colonization in healthy Dutch children
    D Bogaert
    Department of Pediatrics, Erasmus MC Sophia, Room Ee 1500, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
    Microbiology 152:377-85. 2006
  8. ncbi Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009
    G A Menezes
    Department of Microbiology, Institute of National Importance, Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER, Pondicherry, India
    Clin Microbiol Infect 18:239-45. 2012
  9. ncbi Accuracy of identification and susceptibility results by direct inoculation of Vitek 2 cards from positive BACTEC cultures
    J J Kerremans
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre Rotterdam, The Netherlands
    Eur J Clin Microbiol Infect Dis 23:892-8. 2004
  10. ncbi First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes
    A K van der Bij
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Int J Antimicrob Agents 37:513-8. 2011

Collaborators

Detail Information

Publications14

  1. ncbi The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum β-lactamases in experimental pneumonia in rats
    Wil H F Goessens
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Antimicrob Agents Chemother 57:643-6. 2013
    ..In contrast, tigecycline at 6.25, 12.5, or 25 mg/kg b.i.d. showed dosage-dependent efficacy up to 100% rat survival irrespective of the ESBL character of the infecting organism...
  2. ncbi A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA)
    Andreas Voss
    Radboud University Nijmegen Medical Centre, Nijmegen University Centre of Infectious Diseases, The Netherlands
    Ann Clin Microbiol Antimicrob 6:9. 2007
    ..To determine the true incidence of hGISA/GISA and its consequent clinical impact, methods must be defined that will reliably and reproducibly discriminate these resistant phenotypes from vancomycin susceptible S. aureus (VSSA)...
  3. ncbi [Antibiotic resistance: epidemiological developments and preventive measures]
    W H F Goessens
    Medische Microbiologie en Infectieziekten, s Gravendijkwal 230, 3015 CE Rotterdam
    Ned Tijdschr Geneeskd 151:748-52. 2007
    ..Implementation ofnational guidelines for the treatment of infections will contribute to more efficient use of antibiotics and the control of antibiotic resistance in the Netherlands...
  4. ncbi Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection
    W H F Goessens
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Antimicrob Chemother 59:507-16. 2007
    ....
  5. ncbi Comparison of the COBAS AMPLICOR MTB and BDProbeTec ET assays for detection of Mycobacterium tuberculosis in respiratory specimens
    W H F Goessens
    Erasmus MC, University Medical Center Rotterdam, Dept of Medical Microbiology and Infectious Diseases, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    J Clin Microbiol 43:2563-6. 2005
    ....
  6. ncbi Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type
    A K van der Bij
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Clin Microbiol Infect 18:E369-72. 2012
    ..As MBL-producing isolates cause serious infections that are difficult to treat, the presence of clonally related isolates in various hospitals throughout the Netherlands is of nationwide concern...
  7. ncbi Dynamics of pneumococcal colonization in healthy Dutch children
    D Bogaert
    Department of Pediatrics, Erasmus MC Sophia, Room Ee 1500, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
    Microbiology 152:377-85. 2006
    ..7 % of isolates, respectively. Multidrug resistance was found in 1.9 % of strains. In conclusion, pneumococcal colonization isolates from healthy Dutch children represent a heterogeneous, mostly antibiotic susceptible, genetic population...
  8. ncbi Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009
    G A Menezes
    Department of Microbiology, Institute of National Importance, Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER, Pondicherry, India
    Clin Microbiol Infect 18:239-45. 2012
    ..This is most likely to be due to an increased use of ciprofloxacin as a first-line drug of choice over more traditional antimicrobial agents for the treatment of typhoid fever...
  9. ncbi Accuracy of identification and susceptibility results by direct inoculation of Vitek 2 cards from positive BACTEC cultures
    J J Kerremans
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre Rotterdam, The Netherlands
    Eur J Clin Microbiol Infect Dis 23:892-8. 2004
    ..Susceptibility results for this antibiotic, if obtained using direct inoculation, should not be reported to the clinician...
  10. ncbi First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes
    A K van der Bij
    Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Int J Antimicrob Agents 37:513-8. 2011
    ..This is the first reported outbreak of VIM-2 MBL-producing P. aeruginosa in The Netherlands. Once introduced, VIM-2 MBL-producing P. aeruginosa cause significant infections and are easily spread within the hospital setting...
  11. ncbi Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media
    D Bogaert
    Department of Pediatrics, Erasmus MC-Sophia Rotterdam, The Netherlands
    J Clin Microbiol 43:74-83. 2005
    ..However, within the genetic pneumococcal population structure, a clear shift toward nonvaccine serotype clusters was observed...
  12. ncbi Rapid identification of Staphyloccocus aureus in positive-testing blood cultures by Slidex Staph Plus agglutination test
    J J Kerremans
    J Clin Microbiol 46:395. 2008
  13. ncbi Superior discriminative performance of ceftizoxime disk diffusion test for detecting meticillin-resistant Staphylococcus aureus
    J H T Wagenvoort
    Department of Medical Microbiology, Atrium Medical Centre, P.O. Box 4446, 6401, CX Heerlen, The Netherlands
    Eur J Clin Microbiol Infect Dis 25:405-6. 2006
  14. ncbi Serologic evidence of ehrlichiosis among humans and wild animals in The Netherlands
    J Groen
    Laboratory of Exotic Viral Infections, University Hospital Rotterdam, The Netherlands
    Eur J Clin Microbiol Infect Dis 21:46-9. 2002
    ..Furthermore, granulocytic Ehrlichia are most prevalent in humans and animals in The Netherlands...